These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38983260)

  • 1. Access to PrEP and other sexual health services for cisgender women in the United States: a review of state policy and Medicaid expansion.
    Chory A; Bond K
    Front Public Health; 2024; 12():1360349. PubMed ID: 38983260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.
    Siegler AJ; Mehta CC; Mouhanna F; Giler RM; Castel A; Pembleton E; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Sullivan PS
    Ann Epidemiol; 2020 May; 45():24-31.e3. PubMed ID: 32336655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Getting youth PrEPared: adolescent consent laws and implications for the availability of PrEP among youth in countries outside of the United States.
    Taggart T; Bond KT; Ritchwood TD; Smith JC
    J Int AIDS Soc; 2019 Jul; 22(7):e25363. PubMed ID: 31369211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring HIV testing and pre-exposure prophylaxis information seeking by combining digital and traditional data.
    Johnson DC; Nobles AL; Caputi TL; Liu M; Leas EC; Strathdee SA; Smith DM; Ayers JW
    BMC Infect Dis; 2021 Feb; 21(1):215. PubMed ID: 33632140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional Disparities in Qualified Health Plans' Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States.
    McManus KA; Powers S; Killelea A; Tello-Trillo S; Rogawski McQuade E
    JAMA Netw Open; 2020 Jun; 3(6):e207445. PubMed ID: 32492164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "PrEP's just to secure you like insurance": a qualitative study on HIV pre-exposure prophylaxis (PrEP) adherence and retention among black cisgender women in Mississippi.
    Willie TC; Monger M; Nunn A; Kershaw T; Stockman JK; Mayer KH; Chan PA; Adimora AA; Mena LA; Knight D; Philllips KA; Baral SD
    BMC Infect Dis; 2021 Oct; 21(1):1102. PubMed ID: 34702165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-Level Discrimination Policies And HIV Pre-Exposure Prophylaxis Adoption Efforts In The US.
    Bonett S; Meanley S; Elsesser S; Bauermeister J
    Health Aff (Millwood); 2020 Sep; 39(9):1575-1582. PubMed ID: 32897779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Care Coverage and Preexposure Prophylaxis (PrEP) Use Among Men Who Have Sex With Men Living in 22 US Cities With vs Without Medicaid Expansion, 2017.
    Baugher AR; Finlayson T; Lewis R; Sionean C; Whiteman A; Wejnert C;
    Am J Public Health; 2021 Apr; 111(4):743-751. PubMed ID: 33476242
    [No Abstract]   [Full Text] [Related]  

  • 10. The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis.
    Farmer EK; Koren DE; Cha A; Grossman K; Cates DW
    AIDS Patient Care STDS; 2019 May; 33(5):207-213. PubMed ID: 31067124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State health policies and interest in PrEP: evidence from Google Trends.
    Farkhad BF; Nazari M; Chan MS; Albarracín D
    AIDS Care; 2022 Mar; 34(3):331-339. PubMed ID: 34191662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ending HIV Transmission in Australia: Expanding PrEP to Cisgender Women: A Scoping Review.
    MacPhail C; Manlik K; Dews H; Mao L; Rutherford A
    AIDS Behav; 2024 Sep; 28(9):3038-3050. PubMed ID: 38806843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic, clinical guideline criteria, Medicaid expansion and state of residency: a multilevel analysis of PrEP use on a large US sample.
    Carneiro PB; Mirzayi C; Jones S; Rendina J; Grov C
    BMJ Open; 2022 Feb; 12(2):e055487. PubMed ID: 35110323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for Health Care Access and Health Services Use, Adults Aged 18-64 Years - Behavioral Risk Factor Surveillance System, United States, 2014.
    Okoro CA; Zhao G; Fox JB; Eke PI; Greenlund KJ; Town M
    MMWR Surveill Summ; 2017 Feb; 66(7):1-42. PubMed ID: 28231239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of an Educational Intervention to Improve HIV Pre-Exposure Prophylaxis Services for Women in an Urban Sexual Health Clinic.
    Scott RK; Deyarmond M; Marwitz S; Huang JC; Moriarty P; Visconti AJ; Beverley J; Elion R; Coleman M; Hull SJ
    AIDS Patient Care STDS; 2023 Sep; 37(9):447-457. PubMed ID: 37713289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the National Dependent Coverage Expansion With Insurance Use for Sexual and Reproductive Health Services by Female Young Adults.
    Ellison JE; Hanchate AD; Kazis LE; Cole MB
    JAMA Netw Open; 2020 Dec; 3(12):e2030214. PubMed ID: 33337495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.
    Calabrese SK; Magnus M; Mayer KH; Krakower DS; Eldahan AI; Gaston Hawkins LA; Hansen NB; Kershaw TS; Underhill K; Betancourt JR; Dovidio JF
    PLoS One; 2016; 11(6):e0157324. PubMed ID: 27304883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015-2016.
    Chan SS; Chappel AR; Maddox KEJ; Hoover KW; Huang YA; Zhu W; Cohen SM; Klein PW; De Lew N
    PLoS Med; 2020 Apr; 17(4):e1003072. PubMed ID: 32275654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provider views of pre-exposure prophylaxis (PrEP) for cisgender women - where do women fit in HIV elimination in Australia?
    Lade C; MacPhail C; Rutherford A
    Sex Health; 2023 Dec; 20(6):558-565. PubMed ID: 37903431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying an Evidence-Based Community Organizing Approach to Strengthen HIV Prevention for Cisgender Women in US South: Protocol for a Mixed Methods Study.
    Sheth AN; Dixon Diallo D; Ellison C; Er DL; Ntukogu A; Komro KA; Sales JM
    JMIR Res Protoc; 2024 Mar; 13():e56293. PubMed ID: 38517456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.